{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T17:34:01Z","timestamp":1790444041286,"version":"4.1.0"},"reference-count":38,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,8,1]],"date-time":"2017-08-01T00:00:00Z","timestamp":1501545600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","jccjournal.org","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Critical Care"],"published-print":{"date-parts":[[2017,8]]},"DOI":"10.1016\/j.jcrc.2017.04.028","type":"journal-article","created":{"date-parts":[[2017,4,22]],"date-time":"2017-04-22T00:33:02Z","timestamp":1492821182000},"page":"243-250","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":30,"special_numbering":"C","title":["Potential drug-drug interactions in pediatric patients admitted to intensive care unit of Khyber Teaching Hospital, Peshawar, Pakistan: A cross-sectional study"],"prefix":"10.1016","volume":"40","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7227-3399","authenticated-orcid":false,"given":"Mohammad","family":"Ismail","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sana","family":"Aziz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sidra","family":"Noor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iqbal","family":"Haider","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Faryal","family":"Shams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Inamul","family":"Haq","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Faiza","family":"Khadim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qasim","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fahadullah","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad","family":"Asif","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jcrc.2017.04.028_bb0005","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1001\/archpediatrics.2011.161","article-title":"Prevalence of polypharmacy exposure among hospitalized children in the United States","volume":"166","author":"Feudtner","year":"2012","journal-title":"Arch Pediatr Adolesc Med"},{"key":"10.1016\/j.jcrc.2017.04.028_bb0010","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2012-001868","article-title":"Adverse drug events in a paediatric intensive care unit: a prospective cohort","volume":"3","author":"Silva","year":"2013","journal-title":"BMJ Open"},{"key":"10.1016\/j.jcrc.2017.04.028_bb0015","doi-asserted-by":"crossref","DOI":"10.1097\/PCC.0000000000000684","article-title":"Epidemiology of polypharmacy and potential drug\u2013drug interactions among pediatric patients in ICUs of US Children's hospitals","volume":"17","author":"Dai","year":"2016","journal-title":"Pediatr Crit Care Med"},{"key":"10.1016\/j.jcrc.2017.04.028_bb0020","first-page":"401","article-title":"Frequency, levels and predictors of potential drug-drug interactions in a pediatrics ward of a teaching hospital in Pakistan","volume":"12","author":"Ismail","year":"2013","journal-title":"Trop J Pharm Res"},{"key":"10.1016\/j.jcrc.2017.04.028_bb0025","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1007\/s11096-010-9445-2","article-title":"Evaluation of three brands of drug interaction software for use in intensive care units","volume":"32","author":"Reis","year":"2010","journal-title":"Pharm World Sci"},{"key":"10.1016\/j.jcrc.2017.04.028_bb0030","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/j.jsps.2014.11.014","article-title":"Clinical relevancy and risks of potential drug\u2013drug interactions in intensive therapy","volume":"23","author":"Rodrigues","year":"2015","journal-title":"Saudi Pharm J"},{"key":"10.1016\/j.jcrc.2017.04.028_bb0035","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1590\/S1807-59322011000100003","article-title":"Prevalence of potential drug interactions in patients in an intensive care unit of a university hospital in Brazil","volume":"66","author":"Reis","year":"2011","journal-title":"Clinics (Sao Paulo)"},{"key":"10.1016\/j.jcrc.2017.04.028_bb0040","doi-asserted-by":"crossref","first-page":"379","DOI":"10.2165\/00002018-200730050-00003","article-title":"Drug-related problems in hospitals: a review of the recent literature","volume":"30","author":"Krahenbuhl-Melcher","year":"2007","journal-title":"Drug Saf"},{"key":"10.1016\/j.jcrc.2017.04.028_bb0045","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1038\/bjc.2013.48","article-title":"Prevalence of potential drug-drug interactions in cancer patients treated with oral anticancer drugs","volume":"108","author":"van Leeuwen","year":"2013","journal-title":"Br J Cancer"},{"key":"10.1016\/j.jcrc.2017.04.028_bb0050","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1007\/s11096-013-9764-1","article-title":"Potential drug-drug interactions in internal medicine wards in hospital setting in Pakistan","volume":"35","author":"Ismail","year":"2013","journal-title":"Int J Clin Pharmacol"},{"key":"10.1016\/j.jcrc.2017.04.028_bb0055","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1002\/pds.2224","article-title":"Frequency and determinants of potential drug-drug interactions in an elderly population receiving regular home visits by GPs-results of the home medication review in the AGnES-studies","volume":"20","author":"Hoffmann","year":"2011","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1016\/j.jcrc.2017.04.028_bb0060","first-page":"1618","article-title":"Potential drug-drug interactions in cardiology ward of a teaching hospital","volume":"6","author":"Ismail","year":"2012","journal-title":"HealthMED"},{"key":"10.1016\/j.jcrc.2017.04.028_bb0065","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1002\/pds.3415","article-title":"Frequency and nature of drug-drug interactions in the intensive care unit","volume":"22","author":"Askari","year":"2013","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1016\/j.jcrc.2017.04.028_bb0070","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1007\/s11096-016-0340-3","article-title":"Potential drug\u2013drug interactions in medical intensive care unit of a tertiary care hospital in Pakistan","volume":"38","author":"Ismail","year":"2016","journal-title":"Int J Clin Pharmacol"},{"key":"10.1016\/j.jcrc.2017.04.028_bb0075","doi-asserted-by":"crossref","first-page":"289","DOI":"10.4314\/tjpr.v11i2.17","article-title":"Potential drug-drug interactions in psychiatric ward of a tertiary care hospital: prevalence, levels and association with risk factors","volume":"11","author":"Ismail","year":"2012","journal-title":"Trop J Pharm Res"},{"key":"10.1016\/j.jcrc.2017.04.028_bb0080","doi-asserted-by":"crossref","first-page":"e99","DOI":"10.1542\/peds.2014-2015","article-title":"Potential drug\u2212 drug interactions in infant, child, and adolescent patients in children's hospitals","volume":"135","author":"Feinstein","year":"2015","journal-title":"Pediatrics"},{"key":"10.1016\/j.jcrc.2017.04.028_bb0085","series-title":"Report of the health system review mission \u2013 Pakistan","author":"World Health Organization","year":"2007"},{"key":"10.1016\/j.jcrc.2017.04.028_bb0090","series-title":"Mariko M","author":"Creese","year":"2004"},{"key":"10.1016\/j.jcrc.2017.04.028_bb0095","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1111\/j.1365-2044.2004.04014.x","article-title":"Drug related critical incidents","volume":"60","author":"Khan","year":"2005","journal-title":"Anaesthesia"},{"key":"10.1016\/j.jcrc.2017.04.028_bb0100","first-page":"S100","article-title":"Pharmaceuticals\u2013strategic considerations in health reforms in Pakistan","volume":"56","author":"Nishtar","year":"2006","journal-title":"J Pak Med Assoc"},{"key":"10.1016\/j.jcrc.2017.04.028_bb0105","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1007\/s11096-008-9246-z","article-title":"Social pharmacy strengthening clinical pharmacy: why pharmaceutical policy research is needed in Pakistan?","volume":"30","author":"Babar","year":"2008","journal-title":"Pharm World Sci"},{"key":"10.1016\/j.jcrc.2017.04.028_bb0110","unstructured":"Micromedex Drug-Reax\u00ae, Greenwood Village, CO: Truven Health Analytics., http:\/\/www.micromedexsolutions.com\/home\/dispatch; [accessed 10 November, 2016]."},{"key":"10.1016\/j.jcrc.2017.04.028_bb0115","doi-asserted-by":"crossref","first-page":"290","DOI":"10.3163\/1536-5050.104.4.007","article-title":"Evaluation of resources for analyzing drug interactions","volume":"104","author":"Patel","year":"2016","journal-title":"J Med Libr Assoc"},{"key":"10.1016\/j.jcrc.2017.04.028_bb0120","doi-asserted-by":"crossref","first-page":"257","DOI":"10.4103\/2279-042X.192461","article-title":"A comparison of five common drug\u2013drug interaction software programs regarding accuracy and comprehensiveness","volume":"5","author":"Kheshti","year":"2016","journal-title":"J Res Pharm Pract"},{"key":"10.1016\/j.jcrc.2017.04.028_bb0125","series-title":"Drug Interaction Facts: Facts and Comparisons","author":"Tatro","year":"2009"},{"key":"10.1016\/j.jcrc.2017.04.028_bb0130","series-title":"9th Editon","author":"Stockley's","year":"2010"},{"key":"10.1016\/j.jcrc.2017.04.028_bb0135","first-page":"125","article-title":"Assessment of prevalence of potential drug-drug interactions in medical intensive care unit of a tertiary care hospital in india","volume":"8","author":"Abideen","year":"2015","journal-title":"Asian J Pharm Clin Res"},{"key":"10.1016\/j.jcrc.2017.04.028_bb0140","first-page":"87","article-title":"Drug\u2013drug interactions prevalence in intensive care unit patients of a university hospital in Iran","volume":"3","author":"Hasanloei","year":"2014","journal-title":"Bull Env Pharmacol Life Sci"},{"key":"10.1016\/j.jcrc.2017.04.028_bb0145","article-title":"Prevalence and pattern of potential drug-drug interactions in the critical care units of a tertiary hospital in Alexandria","volume":"2013","author":"Mohamed","year":"2014","journal-title":"Egypt Adv in Pharmacoepidemiol Drug Saf"},{"key":"10.1016\/j.jcrc.2017.04.028_bb0150","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1007\/s11096-012-9642-2","article-title":"Evaluation of drug\u2013drug interaction screening software combined with pharmacist intervention","volume":"34","author":"Moura","year":"2012","journal-title":"Int J Clin Pharmacol"},{"key":"10.1016\/j.jcrc.2017.04.028_bb0155","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.2165\/00002018-200528120-00007","article-title":"Clinical relevance of drug-drug interactions","volume":"28","author":"van Roon","year":"2005","journal-title":"Drug Saf"},{"key":"10.1016\/j.jcrc.2017.04.028_bb0160","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1016\/j.ijcard.2015.10.206","article-title":"Clinical-pharmacist intervention reduces clinically relevant drug\u2013drug interactions in patients with heart failure: a randomized, double-blind, controlled trial","volume":"203","author":"Roblek","year":"2016","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.jcrc.2017.04.028_bb0165","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.2165\/11316700-000000000-00000","article-title":"Laboratory tests in the clinical risk management of potential drug-drug interactions","volume":"32","author":"Geerts","year":"2009","journal-title":"Drug Saf"},{"key":"10.1016\/j.jcrc.2017.04.028_bb0170","first-page":"mdv029","article-title":"Drug\u2013drug interactions in patients treated for cancer: a prospective study on clinical interventions","author":"van Leeuwen","year":"2015","journal-title":"Ann Oncol"},{"key":"10.1016\/j.jcrc.2017.04.028_bb0175","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1093\/jnci\/djk130","article-title":"Potential drug interactions and duplicate prescriptions among cancer patients","volume":"99","author":"Riechelmann","year":"2007","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.jcrc.2017.04.028_bb0180","doi-asserted-by":"crossref","first-page":"911","DOI":"10.2165\/00002018-200730100-00009","article-title":"The relationship between number of drugs and potential drug-drug interactions in the elderly: a study of over 600,000 elderly patients from the Swedish prescribed drug register","volume":"30","author":"Johnell","year":"2007","journal-title":"Drug Saf"},{"key":"10.1016\/j.jcrc.2017.04.028_bb0185","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1111\/j.1365-2125.2009.03443.x","article-title":"Frequency and nature of drug\u2013drug interactions in a Dutch university hospital","volume":"68","author":"Zwart-van Rijkom","year":"2009","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.jcrc.2017.04.028_bb0190","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1590\/S1807-59322006000600005","article-title":"A pharmacoepidemiologic study of drug interactions in a Brazilian teaching hospital","volume":"61","author":"Cruciol-Souza","year":"2006","journal-title":"Clinics"}],"container-title":["Journal of Critical Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0883944117302605?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0883944117302605?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,2]],"date-time":"2018-09-02T09:53:51Z","timestamp":1535882031000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0883944117302605"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8]]},"references-count":38,"alternative-id":["S0883944117302605"],"URL":"https:\/\/doi.org\/10.1016\/j.jcrc.2017.04.028","relation":{},"ISSN":["0883-9441"],"issn-type":[{"value":"0883-9441","type":"print"}],"subject":[],"published":{"date-parts":[[2017,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Potential drug-drug interactions in pediatric patients admitted to intensive care unit of Khyber Teaching Hospital, Peshawar, Pakistan: A cross-sectional study","name":"articletitle","label":"Article Title"},{"value":"Journal of Critical Care","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcrc.2017.04.028","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}